Beijing, China

Kun Zheng

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Jenkem Technology Co., Ltd. (Beijing). Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kun Zheng. Retrieved from https://idiyas.com/inventor/kun-zheng-kbjph2hx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kun Zheng - Innovator in Drug Delivery Systems

Introduction

Kun Zheng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical technology, particularly in drug delivery systems. His innovative work focuses on enhancing drug efficacy through advanced conjugate designs.

Latest Patents

Kun Zheng holds a patent for a PEG linker and ligand drug conjugate. This invention features a PEG linker represented by a specific formula, wherein n and m are integers ranging from 1 to 7. This design provides the PEG linker with 1 to 49 linking sites. The ligand drug conjugate utilizes the PEG linker to increase drug loading capacity and diversity, thereby improving pharmaceutical efficacy.

Career Highlights

Kun Zheng is associated with Jenkem Technology Co., Ltd. in Beijing. His work at this company has been instrumental in advancing drug delivery technologies. He has dedicated his career to developing innovative solutions that address critical challenges in the pharmaceutical industry.

Collaborations

Kun Zheng collaborates with notable colleagues, including Yanping Song and Wen Li. Their combined expertise contributes to the success of their projects and enhances the research environment at Jenkem Technology Co., Ltd.

Conclusion

Kun Zheng's contributions to drug delivery systems exemplify the impact of innovation in pharmaceuticals. His patent for a PEG linker and ligand drug conjugate showcases his commitment to improving drug efficacy. Through his work, he continues to influence the future of pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…